Revision history of "Epigenetics and immunosuppression. Use of circulating histones and their post-translational modifications as biomarkers for diagnosis and prognosis in sepsis and septic shock." (Q3138351)

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

9 October 2024

  • curprev 22:4322:43, 9 October 2024DG Regio talk contribs 69,040 bytes +9 Changed label, description and/or aliases in pt
  • curprev 22:4322:43, 9 October 2024DG Regio talk contribs 69,031 bytes +16 Set a claim value: summary (P836): A sepse tem uma incidência na Europa de 200 a 300 casos por 100 000 habitantes/ano. 2 % dos doentes hospitalizados e 75 % dos doentes em UTI desenvolvem uma sepse, dos quais 30 % evoluem para choque séptico (SS). Além disso, muitos dos sobreviventes desenvolvem uma imunossupressão que os torna mais sensíveis a novas infeções e leva a um aumento da morbilidade-mortalidade a longo prazo. Recentemente, tem sido recomendada a procura de novos biomarcado...

12 March 2024

20 December 2023

12 June 2023

10 June 2023

17 August 2022

  • curprev 19:3119:31, 17 August 2022DG Regio talk contribs 67,742 bytes +45,950 Changed label, description and/or aliases in el, da, fi, mt, lv, sk, ga, cs, pt, et, hu, bg, lt, hr, sv, ro, sl, pl, nl, fr, de, it, es, and other parts: Adding translations: el, da, fi, mt, lv, sk, ga, cs, pt, et, hu, bg, lt, hr, sv, ro, sl, pl,

16 January 2022

17 December 2021

9 December 2021

2 December 2021

  • curprev 11:1711:17, 2 December 2021DG Regio talk contribs 14,692 bytes +2,285 Created claim: summary (P836): L’incidence de la septicémie en Europe est de 200 à 300 cas pour 100 000 habitants/an. 2 % des patients hospitalisés et 75 % des patients en soins intensifs développent une septicémie, dont 30 % évoluent vers un choc septique (SS). De plus, bon nombre des survivants développent une immunosuppression qui les rend plus sensibles aux nouvelles infections et entraîne une augmentation de la morbidité et de la mortalité à long terme. Récemment, il a é...
  • curprev 11:1711:17, 2 December 2021DG Regio talk contribs 12,407 bytes +276 Changed label, description and/or aliases in fr: translated_label

12 October 2021

  • curprev 13:0213:02, 12 October 2021DG Regio talk contribs 12,131 bytes +235 Changed label, description and/or aliases in en: translated_label
  • curprev 13:0213:02, 12 October 2021DG Regio talk contribs 11,896 bytes +2,010 Created claim: summary (P836): Sepsis has an incidence in Europe of 200-300 cases per 100,000 inhabitants/year. 2 % of hospitalised patients and 75 % of ICU patients develop a sepsis, of which 30 % evolve to septic shock (SS). In addition, many of the survivors develop an immunosuppression that makes them more sensitive to new infections and leads to an increase in long-term morbidity-mortality. Recently, it has been recommended the search for new sensitive and specific bioma...

10 October 2021

9 October 2021

7 October 2021